SRSF9 and hepatocellular carcinoma: Our results revealed that all seven methylation sites of SRSF9 remained hypomethylated in HCC and showed identified that the methylation status of cg06116271 could negatively regulate the expression of SRSF9. Importantly, the hypermethylation of cg06116271 was associated with a better prognosis in patients with HCC.